The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?

@inproceedings{Kehoe2018TheCO,
  title={The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?},
  author={Patrick G Kehoe},
  booktitle={Journal of Alzheimer's disease : JAD},
  year={2018}
}
There is wide recognition of a complex association between midlife hypertension and cardiovascular disease and later development of Alzheimer's disease (AD) and cognitive impairment. While significant progress has been made in reducing rates of mortality and morbidity due to cardiovascular disease over the last thirty years, progress towards effective treatments for AD has been slower. Despite the known association between hypertension and dementia, research into each disease has largely been… CONTINUE READING
7
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 230 REFERENCES

Telmisartan prevented cognitive decline partly due to PPAR-gamma activation.

  • Biochemical and biophysical research communications
  • 2008
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Cerebral Aβ40 and systemic hypertension.

  • Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
  • 2017
VIEW 2 EXCERPTS